Kriya Medical Technologies announced that it has got a manufacturing licence from the Drugs Controller General of India (DCGI) for its product KRIVIDA Novus. This RT-PCR kit can detect the Omicron variant and its sub-lineages in 45 minutes. The kit prices at Rs 150 plus taxes, the company said in a statement.

The company said it would launch the kit from its Chennai-based manufacturing facility. The company currently has a production capacity of 5 million tests per month and will increase it up to 10 million tests per month in the next two weeks. “Our focus is to make testing for Covid-19 variants faster, affordable and available to everyone, and enabling fast prevention and timely treatment. Since KRIVIDA Novus can detect the Omicron variant and its sub-lineages like BA.1, BA.2 and BA.3 in 45 minutes, it is most ideal and beneficial for entry point screening at airports and organisation of normal conditions in the workplace and institutions,” Kriya Medical Technologies CEO and Founder Anu Moturi said.